Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Circulation

• Publication date

  1997-08-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.96.3.748PMID 9264478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction.

  1996cited by this paper
• Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base. Gruppo Italiano per lo Studio della Sopravvivenza Nell'Infarto.

  1995cited by this paper
• Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base

  1995cited by this paper
• Cardiologists' practices compared with practice guidelines: use of beta-blockade after acute myocardial infarction.

  1995cited by this paper
• Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group.

  1995cited by this paper
• Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI Investigators.

  1995cited by this paper
• Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. The ACIP Investigators.

  1995cited by this paper
• Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

  1994cited by this paper
• A Prospective, Placebo‐Controlled, Randomized Trial of Intravenous Streptokinase and Angioplasty Versus Lone Angioplasty Therapy of Acute Myocardial Infarction

  1992cited by this paper
• SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group.

  1991cited by this paper
• Impact of unstable angina on operative mortality with coronary revascularization at varying time intervals after myocardial infarction.

  1991cited by this paper
• Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

  1990cited by this paper
• Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction.

  1990cited by this paper
• Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

  1990cited by this paper
• Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial.

  1989cited by this paper
• Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty.

  1988cited by this paper
• Twelve-year follow-up of survival in the randomized European Coronary Surgery Study.

  1988cited by this paper
• Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.

  1988cited by this paper
• Silent ischaemia following myocardial infarction: frequency, characteristics and prognosis.

  1988cited by this paper
• A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.

  1987cited by this paper
• IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION: A Randomised Trial by the Interuniversity Cardiology Institute in The Netherlands

  1985cited by this paper
• Evaluation of a QRS scoring system for estimating myocardial infarct size. V. Specificity and method of application of the complete system.

  1985cited by this paper
• Effect of Intracoronary Thrombolytic Therapy on Left Ventricular Function and Mortality in Patients with Acute Myocardial Infarction: Preliminary Results of the Thoraxcenter Randomised Trial

  1985cited by this paper
• Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older. A nonrandomized study from the Coronary Artery Surgery Study (CASS) registry.

  1985cited by this paper
• Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina.

  1984cited by this paper

• Thrombolytics for Myocardial Infarction, Where Progress meets Pragmatism.

  2026cites this paper
• National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Comprehensive Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025.

  2025cites this paper
• Digital health for improving management of acute coronary syndrome

  2023cites this paper
• Mortality in Patients with Acute Coronary Syndrome—A Prospective 5-Year Follow-Up Study

  2023cites this paper
• Rassegne Più rischi meno trattamenti : il paradosso degli anziani con sindromi coronariche acute

  2020cites this paper
• Vessel-specific coronary perfusion territories using a CT angiogram with a minimum cost path technique and its direct comparison to the American Heart Association 17-segment model

  2020cites this paper
• JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome.

  2019cites this paper
• Isolation, Characterization and Cardioprotective Potential of Gratissinol from Chloroform Extract of Ocimum Gratissimum (Linn.) Leaves

  2019cites this paper
• Myocardial Mass Contributes to the Discrepancy Between Anatomic Stenosis Severity Assessed by Intravascular Ultrasound and Fractional Flow Reserve in Intermediate Lesions of the Coronary Artery

  2018cites this paper
• Evaluating Treatment and Diagnostics in Cardiac Intervention

  2018cites this paper
• Urgent versus elective coronary artery bypass grafting in acute coronary artery syndrome

  2018cites this paper
• Quantification of vessel-specific coronary perfusion territories using minimum-cost path assignment and computed tomography angiography: Validation in a swine model.

  2018cites this paper
• Long-Term Survival Among Patients With Myocardial Infarction Before Age 50 Compared With the General Population

  2016cites this paper
• Early Invasive Strategy for Unstable Angina: a New Meta-Analysis of Old Clinical Trials

  2016cites this paper
• Routine invasive versus selective invasive strategies for Non‐ST‐elevation acute coronary syndromes: An Updated meta‐analysis of randomized trials

  2016cites this paper
• Long-Term Survival Among Patients With Myocardial Infarction Before Age 50 Compared With the General Population: A Danish Nationwide Cohort Study

  2016cites this paper
• Addition of Exercise to Dipyridamole Stress Echocardiography in Order to Carry on the Ischemic Cascade: Role in the Diagnosis of Coronary Artery Disease and Prognostic Value

  2016cites this paper
• Kardiologische Ursachen für Thoraxschmerz

  2016cites this paper
• Metodo di ricerca ECG da sforzo ed eco-stress dobutamina nella stratificazione del rischio dopo infarto miocardico acuto non complicato

  2015cites this paper
• Coronary Artery Bypass Surgery and Percutaneous Coronary Revascularization: Impact on Morbidity and Mortality in Patients with Coronary Artery Disease

  2015cites this paper
• Guía de Práctica Clínica de la ESC 2013 sobre diagnóstico y tratamiento de la cardiopatía isquémica estable

  2014cites this paper
• Pre-Hospital ECG E-Transmission for Patients with Suspected Myocardial Infarction in the Highlands of Scotland

  2014cites this paper
• Influence of hyperbaric oxygenation treatment (HBOT) on clinical outcomes (recurrent myocardial infarction and survival rate) during five-year monitoring period after acute myocardial infarction

  2014cites this paper
• Analiza primene reperfuzione terapije u odnosu na procenjeni stepen rizika bolesnika sa akutnim infarktom miokarda sa elevacijom ST segmenta u Srbiji

  2014cites this paper
• Task Force on Practice Guidelines A Report of the American College of Cardiology Foundation/American Heart Association 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction:

  2014cites this paper
• 2013 ACCF/AHA Guideline for the Management of ST‐Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2013cites this paper
• Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design.

  2013cites this paper
• Wytyczne ESC dotyczące postępowania w stabilnej chorobie wieńcowej w 2013 roku Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw postępowania w stabilnej chorobie wieńcowej

  2013cites this paper
• 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cites this paper
• 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cites this paper
• 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

  2013cites this paper
• 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention

  2013cites this paper
• ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation

  2013influential citation
• Acute Myocardial Infarction in patients presenting with ST-segment elevation (Management of)

  2013influential citation
• A prospective regional registry of ST-elevation myocardial infarction in Central Romania: impact of the Stent for Life Initiative recommendations on patient outcomes.

  2013cites this paper
• 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cites this paper
• Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST

  2013cites this paper
• 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cites this paper
• Guidelines for Secondary Prevention of Myocardial Infarction (JCS 2011).

  2012cites this paper
• The role of exercise testing in the interventional era: a shift of focus

  2012cites this paper
• Long-Term Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drug Use According to Time Passed After First-Time Myocardial Infarction: A Nationwide Cohort Study

  2012cites this paper
• Wytyczne ESC dotyczące postępowania w ostrym zawale serca z przetrwałym uniesieniem odcinka ST Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw postępowania w ostrym zawale serca z uniesieniem odcinka ST

  2012cites this paper
• Modern management of acute myocardial infarction.

  2012cites this paper
• 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive Summary

  2012cites this paper
• Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology ( ESC )

  2012cites this paper
• Chapter 10 – ST-Segment Elevation Myocardial Infarction

  2012cites this paper
• Aligning Coronary Anatomy and Myocardial Perfusion Territories: An Algorithm for the CORE320 Multicenter Study

  2012cites this paper
• Did we pass the border? Routine multivessel intervention in STEMI patients.

  2012cites this paper
• ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

  2012influential citation
• ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

  2012cites this paper
• Management of ST-elevation myocardial infarction

  2011cites this paper
• 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2011cites this paper
• Prognostic Risk Stratification After Acute Coronary Syndromes

  2011cites this paper
• Response to Letters Regarding Article, “Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction: A Nationwide Cohort Study”

  2011cites this paper
• 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

  2011cites this paper
• Use of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography in Assessment of Cardiovascular Disease Risk and Atherosclerosis Progression

  2011cites this paper
• ACCF/AHA/SCAI Practice Guideline 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi

  2011cites this paper
• 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

  2011cites this paper
• Does nickel allergy play a role in the development of in-stent restenosis?

  2011cites this paper
• 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in c

  2011cites this paper
• 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

  2011cites this paper
• 2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2011cites this paper
• The editor's roundtable: role of percutaneous coronary intervention and drug-eluting stents in patients with stable coronary heart disease.

  2011cites this paper
• the Society for Cardiovascular Angiography and Interventions Foundation/American Heart Association Task Force on Practice Guidelines and Executive Summary : A Report of the American College of Cardiology 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention:

  2011cites this paper
• Ruptura de la pared libre ventricular y del septo interventricular como complicaciones del infarto agudo de miocardio en la población española: pronóstico y factores predictores de su desarrollo

  2011cites this paper
• Routine early coronary angioplasty after thrombolysis in acute ST-elevation myocardial infarction: lysis is not the final step.

  2011cites this paper
• Correspondence Response to Letters Regarding Article , “ Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction : A Nationwide Cohort Study ”

  2011cites this paper
• ST Elevation Myocardial Infarction

  2011cites this paper
• ACCF/AHA/SCAI Practice Guideline 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions

  2011cites this paper
• Should oxygen be given in myocardial infarction?

  2010cites this paper
• Chapter 35 – Risk Stratification after Acute ST-Segment Elevation and Non-ST-Segment Elevation Myocardial Infarction

  2010cites this paper
• Reperfusion therapy, reocclusion and disease progression in acute myocardial infarction

  2010cites this paper
• CHAPTER 12 – Reperfusion Therapies for Acute ST Segment Elevation Myocardial Infarction

  2010cites this paper
• Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization.

  2010cites this paper
• Long-term effects of invasive treatment in patients with a post-thrombolytic Q-wave myocardial infarction

  2010cites this paper
• [Predictive value of inflammation and myocardial necrosis markers in acute coronary syndrome].

  2010cites this paper
• CHAPTER 16 – Recurrent Ischemia after Reperfusion Therapy for Acute Myocardial Infarction

  2010cites this paper
• Infarto de miocardio: rutina de tratamiento en el hospital y al alta, fármacos, valoración del riesgo, rehabilitación y prevención secundaria

  2009cites this paper
• 7 Management of Acute Coronary Syndrome in the Light of Recent Trials

  2009cites this paper
• Percutaneous coronary intervention following thrombolysis: For whom and when?

  2009cites this paper
• Estrategias de reperfusión en el infarto agudo de miocardio con elevación del segmento ST. Visión general y descripción de conceptos. Situación actual de la reperfusión farmacológica en España

  2009cites this paper
• The effect of place of residence on access to invasive cardiac services following acute myocardial infarction.

  2009cites this paper
• Longer-term follow-up of patients recruited to the REACT (Rescue Angioplasty Versus Conservative Treatment or Repeat Thrombolysis) trial.

  2009cites this paper
• Il fenomeno del no-reflow: significato clinico e aspetti diagnostici e terapeutici

  2009cites this paper
• Impact of stress testing before percutaneous coronary intervention or medical management on outcomes of patients with persistent total occlusion after myocardial infarction: analysis from the occluded artery trial.

  2009cites this paper
• Clinical aspects of silent myocardial ischaemia : with particular reference to diabetes mellitus : achieving best practice

  2009cites this paper
• Impact of Stress Testing Prior to PCI or Medical Management on Outcomes of Patients With Persistent Total Occlusion After Myocardial Infarction : Analysis From the Occluded Artery Trial

  2009cites this paper
• The impact of revascularization on mortality in patients with nonacute coronary artery disease.

  2009cites this paper
• Coronary revascularization in patients with stable or asymptomatic coronary artery disease: A review of the COURAGE trial

  2008cites this paper
• Coronary artery bypass surgery or percutaneous coronary intervention after fibrinolysis: a critical reappraisal.

  2008cites this paper
• Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis.

  2008cites this paper
• Diagnosis and Treatment of Unstable Angina

  2008cites this paper
• Efectos de la reperfusión tardía en el infarto sobre la morbimortalidad y la función ventricular izquierda: metaanálisis de estudios aleatorizados

  2008cites this paper
• New data on early management of patients with ST-elevation myocardial infarction

  2008cites this paper
• Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial.

  2008cites this paper
• Angioplasty Strategies in ST-Segment–Elevation Myocardial Infarction: Part I: Primary Percutaneous Coronary Intervention

  2008cites this paper
• Angioplasty Strategies in ST-Segment–Elevation Myocardial Infarction: Part II: Intervention After Fibrinolytic Therapy, Integrated Treatment Recommendations, and Future Directions

  2008cites this paper
• Commentary: the role of percutaneous coronary intervention in ST-segment-elevation myocardial infarction.

  2008cites this paper
• Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time?

  2008cites this paper
• Percutaneous coronary intervention for stable coronary artery disease.

  2008cites this paper